News & Press Releases

Filter
467 found
Midwife Amichia Solange & Angelica Konate outside their health centre in Cote d'Ivoire

WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester

28 Nov 2022
R&D, Partner, Access & product management
Young father holding his baby and kissing him on the cheek

Strong Recommendation for Pyronaridine-Artesunate in Revised WHO Malaria Treatment Guidelines

25 Nov 2022
Partner, Access & product management
Young Ugandan school children sitting at desks turning to look at the camera

Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria

23 Nov 2022
R&D, Partner
A group photo of the RBM Malaria in Pregnancy Working Group meeting attendees outside a tent at Ridge Hospital in Accra

RBM Malaria in Pregnancy Working Group meeting in Accra

30 Sep 2022
General

First African-manufactured medicine to prevent malaria in pregnant women and infants quality-approved by WHO

25 Aug 2022
Access & product management

MMV and IVCC make 240 compounds available to stimulate research into new drugs and insecticides

13 Aug 2022
R&D, Open source

MMV announces the start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol

22 Jul 2022
Access & product management

MMV echoes Fight the Fakes Alliance’s call for Global Fund Replenishment to prevent increase in falsified medicines

14 Jul 2022
Access & product management

MMV awards Project of the Year 2021 to GSK for the discovery of GSK484

12 Jul 2022
R&D
A photo of David Reddy standing at a lectern and speaking at the Kigali Summit

MMV’s Dr David Reddy makes commitment at the Kigali Summit

27 Jun 2022
General

MMV’s CSO Dr Timothy Wells awarded honorary degree from University of Dundee

23 Jun 2022
R&D

This World Malaria Day MMV joins Swiss Malaria Group in calling for increased commitment to combatting malaria

22 Apr 2022
Partner

MMV welcomes Alan Court as new Board Chair

12 Apr 2022
General

Dr Pedro Alonso retires from position as Director of WHO’s Global Malaria Programme

01 Apr 2022
General
Boards for all? A review of power, policy and people on the boards of organisations active in global health. Read now at bit.ly/GH50502022. #Boardsforall. A picture of a double-pan balance with silhouettes of men in suits in one pan and a lone woman in the other.

Global Health 50/50 launches report Boards for all?

30 Mar 2022
General

Single-dose Kozenis (tafenoquine) approved for children with Plasmodium vivax malaria by Australian Therapeutic Goods Administration

14 Mar 2022
Access & product management

Professor Michael Ferguson receives British Society for Parasitology Honorary Membership

04 Mar 2022
R&D

Ongoing challenges and renewed commitment: MMV’s progress in 2021

14 Dec 2021
General

MMV supports open letter urging decision makers to scale-up access to preventive malaria treatment in pregnancy

10 Dec 2021
General

Malaria kills more children than previously estimated according to World Malaria Report

06 Dec 2021

MMV deeply saddened by the loss of Dr Martin de Smet

01 Dec 2021
Access & product management

MMV launches innovative drug research tool

01 Dec 2021
R&D

Dr Elizabeth Winzeler elected to the National Academy of Medicine

21 Oct 2021
General

First-ever malaria vaccine to get WHO recommendation for roll-out

07 Oct 2021
Partner

First real-world use of new protocol for P. vivax case management in Brazil – a Health Ministry and MMV collaboration

07 Oct 2021
Access & product management

Novartis and Medicines for Malaria Venture report positive results for Phase IIb study of novel ganaplacide/lumefantrine combination in children with malaria

29 Sep 2021
R&D

MMV mourns the loss of Dr Tachi Yamada

15 Aug 2021
General

New partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide

14 Jul 2021
Access & product management

Pyronaridine-artesunate demonstrates high real-life safety, tolerability and effectiveness in the treatment of uncomplicated malaria in large multi-country study in Africa

17 Jun 2021
R&D

MMV devises a predictive tool to assess resistance to antimalarial compounds and guide their development

31 May 2021
R&D

MMV and DNDi urge WHO member states to invest in medicines for women and children

27 May 2021
General

MMV and partners recognize malaria innovations and urge WHO member states to scale up investments

26 May 2021
General

MMV deeply saddened by the loss of Ambassador Dr Konji Sebati

18 May 2021
General

MMV recognizes partner Novartis’ milestone of 1 billion courses of antimalarial delivered

18 May 2021
Partner

SMC scale-up significantly reduces child mortality in the Sahel

10 May 2021
Access & product management

MMV’s partner S Kant receives WHO prequalification for its protective medicine for children

23 Apr 2021
Access & product management

This World Malaria Day MMV recognizes Swiss Malaria Group's commitment to defeating malaria

19 Apr 2021
Partner

MMV mourns the loss of Professor Sir Colin Dollery

29 Jan 2021
General

Republic of Korea grants USD 10 million to MMV-led consortium to protect children from malaria in the Sahel

28 Jan 2021
Access & product management

New report demonstrates how R&D partnerships serving neglected communities have developed dozens of life-saving innovations since 2010

28 Jan 2021
R&D

GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration

08 Jan 2021
Access & product management

MMV awards Project of the Year 2020 to Professor David Fidock and team for critical contribution to malaria drug resistance profiling

18 Dec 2020
R&D

Looking Back at An Extraordinary Year

18 Dec 2020
General

MMV’s Adam Aspinall appointed as Chair of the new Fight the Fakes Alliance

14 Dec 2020
Access & product management

MMV supports the launch of the new Fight the Fakes Alliance

07 Dec 2020
Access & product management

World Malaria Report highlights two decades of progress while calling for increased commitment as gains plateau

30 Nov 2020
General

Largest clinical trial in Africa to treat COVID-19 cases before they become severe

20 Nov 2020
R&D

GSK and MMV present positive data on treatment of Plasmodium vivax malaria

19 Nov 2020
R&D

Endemic countries in South America meet to discuss new tools for malaria elimination

02 Nov 2020
Partner

Global call to boost access to lifesaving malaria treatment for pregnant women in Africa

15 Oct 2020
Partner

Despite early indicators of artemisinin resistance in Rwanda, ACTs continue to cure malaria

19 Aug 2020
R&D, General

MMV awards Project of the Year 2019 to Novartis for the discovery of INE963

13 Jul 2020
R&D

MMV launches Malaria Libre, a new open source drug discovery programme

07 Jul 2020
R&D

ESAC member Sir Simon Campbell inducted into the RSC-BMCS Hall of Fame

30 Jun 2020
R&D, General

MMV deeply saddened by the loss of Dr Ricardo Thompson

26 Jun 2020
General

MMV’s Dr James Duffy appointed to RSC Lectureship

19 Jun 2020
R&D

MMV launches the COVID Box to stimulate new drug research

10 Jun 2020
R&D, Open source

MMV submits statement to 73rd World Health Assembly

19 May 2020
General

This World Malaria Day MMV supports Swiss Malaria Group's call for urgent action

25 Apr 2020
Partner

Thailand becomes first malaria-endemic country in Asia-Pacific to approve tafenoquine for radical cure of P. vivax malaria

24 Apr 2020
Access & product management

Pages